Become a Member

Topic Archives: Sanofi (SNY)

  • De-tease: “Algo Meds” to Cash in on Kohl’s “No. 1 AI Stock of Our Era”

    Digging into a teased "AI Drug Discovery" pitch from Topline Trader

    5 Comments Read More
  • Women, Statins and Curry

    Spring 2023 Short Bits from Doc Gumshoe

    27 Comments Read More
  • Catching Up on COVID and Keeping Up to Date on Monkeypox

    Latest updates from Doc Gumshoe

    30 Comments Read More
  • Is “The End of Alzheimer’s” Going to be “Jeff Bezos’ Next Big Thing?”

    What's being teased by Behind the Markets?

    17 Comments Read More
  • COVID 19: What Are Prospects for the Duration?

    Doc Gumshoe on Arizona, Sweden, Herd Immunity and the Progress of Vaccine Programs

    56 Comments Read More
  • 58,300% Sales Surge for “Super Vaccine” Company?

    What's being touted by Money Morning in ads for Michael Robinson's new Bio-Technology Profit Alliance?

    42 Comments Read More
  • Another Look at COVID 19

    Doc Gumshoe on "a few encouraging items"

    132 Comments Read More
  • What’s Teased as “Our #1 Takeover Target for February?”

    Today we’ve got a teaser pitch from Dylan Jovine’s new service, Takeover Targets, which he says is “half price” for charter subscribers (that would be $997/year, and unlike many higher-end newsletters they say they do offer refunds for 30 days)… and, as you might imagine, the service is all about identifying companies that might be […]

    17 Comments Read More
  • Coronavirus Update – February 2020

    Doc Gumshoe on COVID-19

    51 Comments Read More
  • Combating Cancer: The Current Battle Plan

    Part Two of Doc Gumshoe's look at Cancer in 2019

    25 Comments Read More
  • March 2018 Catch Up: What’s Been Happening in the Pharm World?

    What drugs hit in 2017? How did approvals compare to 2016?

    14 Comments Read More
  • The 2017 – 2018 Flu Outbreak: How Bad Is It Really, and What to Do?

    Doc Gumshoe checks in on influenza

    64 Comments Read More
  • Bulletins from the Cardiac Front

    Doc Gumshoe checks in on PCSK9 inhibitors, statins, and blood pressure

    19 Comments Read More
  • Trump’s “Mystery Holding” teased by Oxford Club

    "The Shocking Surprise I Found in Trump's Personal Stock Portfolio" -- What's the "secretive, under-the rader company with a stranglehold on a super lucrative niche" hinted at by Chris Matthai?

    13 Comments Read More
  • Marc Lichtenfeld “Bets His Paycheck” — “GMS” Stock revealed

    What's being teased as a "guaranteed double" by Lightning Trend Trader?

    51 Comments Read More
  • The Great Gallic Foie Gras Hack

    The New Metabolomics, Second in a Series

    2,422 Comments Read More
  • written by reader Cancer Care: Where Are We and Where Are We Headed?

    [ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]

    36 Comments Read More
  • The 2015 Stock Gumshoe Biotechnology Awards Show!

    THE YEAR THAT WAS

    984 Comments Read More
  • written by reader Biosimilars: What Are They, and Why On Earth Should We Care?

    Doc Gumshoe takes a look at "biologic generics"

    11 Comments Read More
  • written by reader Oxidation for Health…Physical and Fiscal

    [Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]

    1,353 Comments Read More
  • written by reader A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?

    Oh Yeah...It May Prevent Cancer, Too

    798 Comments Read More
  • written by reader Hepatitis with a C

    Second of Two Parts

    932 Comments Read More
  • written by reader Guaranteed Weight Loss without Surgery, Drugs or Dieting! (Really!)

    But Is This Biotech a Good Investment?

    664 Comments Read More
  • written by reader Antibiotics Don’t Get No Respect, But You Can Still Profit From Them

    DR. KSS TAKES ON ANTIBIOTICS

    588 Comments Read More
  • written by reader Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?

    DOC GUMSHOE EXAMINES A NEW CLASS OF NON-STATIN DRUGS

    103 Comments Read More
  • Can you really “Create Extra Paychecks Month After Month Thanks to the ‘MCR Plan?'” (Leeb)

    Figuring out the "Income Stacking" picks teased by Stephen Leeb's Complete Investor

    5 Comments Read More
  • Starting the Year with the Other Experts …

    Most of the time I write about the investment newsletter business — the pundits who sell their expertise, the copywriters who make the mundane seem otherworldly, and the outrageous promises and teases that the publishers use to convince us to subscribe to newsletters that proffer investment research and stock tips. But it’s worth noting that […]

    6 Comments Read More
  • Comments

  • $TSRO $GILD $SNY"Buyout Buzz: Sanofi, Gilead rumors keep the fire burning under a boiling Tesaro buyout story"At...

  • this was a $2.00 stock at the time of the original post above (9 months ago). WOWFlexion Therapeutics - $FLXN +40% j...

  • Pre-market actions, 1/6, per IBD at 8:45amIn Motion: Amgen, Regeneron, Ionis, VerizonPremarket action was a mixe...

  • Sanofi (SNY) and Google teaming up for new start up Onduo targeting diabetes treatments.http://www.xconomy.com/bosto...

  • Long $RLYP http://tinyurl.com/j5bmn49 Short article, and nice summation of current position. RLYP has applied for Eu...

  • I think Sanofi ($SNY) was meant....

  • Sanofi (SNY) on the hunt for rare disease acquisitions.http://finance.yahoo.com/news/100-billion-french-pharma-giant...

  • Doc KSS,First and foremost, glad you are on the mend.I was wondering if you could kindly comment on the effica...

  • Could be, the hints were all over the map on this since he's teasing RNAi generally and hinting at lots of studies done ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info